Drugs / Human Rabies Immunoglobulin (HRIG)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07445815 | Jan → Jul 2026 overdue | — | Lanzhou Institute of Biological Products Co., Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Rabies Immunoglobulin (HRIG) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07445815 ↗ |
| Known as | HRIG | “Human Rabies Immunoglobulin (HRIG)” NCT07445815 ↗ |
| Modality | Protein / enzyme biologic | “Human Rabies Immunoglobulin (HRIG)” NCT07445815 ↗ |
| Route | Intramuscular | “via intramuscular injection” NCT07445815 ↗ |